Careers                    Privacy Notice                    Terms of Use

2020 La Jolla Pharmaceutical Company

 

OUR COMPANY

La Jolla Pharmaceutical Company is dedicated to the commercialization of innovative therapies that improve outcomes in patients suffering from life-threatening diseases. GIAPREZA™ (angiotensin II) is approved by the U.S. Food and Drug Administration (FDA) as a vasoconstrictor indicated to increase blood pressure in adults with septic or other distributive shock. XERAVA™ (eravacycline) is approved by the U.S. FDA for the treatment of complicated intra-abdominal infections.

p4 .jpg
 
 

MANAGEMENT

Larry Edwards
President and Chief Executive Officer
Michael Hearne
Chief Financial Officer
 
Tony Hodges, M.D., FACP, FCCP
Chief Medical Officer
 
Stew Kroll
Chief Development Officer
Luke Seikkula
Senior Vice President of Pharmaceutical Operations
Steven Ferris
Vice President of Quality Assurance
Paula Rusu
Vice President of Operations
Larry Edwards

President and Chief Executive Officer

 

Mr. Edwards has served as President and Chief Executive Officer since 2020. From 2015 to 2020, he served in various positions at Tetraphase Pharmaceuticals, Inc., most recently serving as Chief Executive Officer. From 2014 to 2015, Mr. Edwards served as Senior Director of Marketing of the Gram-negative Franchise of Cubist Pharmaceuticals, Inc. (acquired by Merck & Co., Inc.). From 1999 to 2014, he served in various positions at Merck and Co., Inc., most recently serving as Global Marketing Director of Clostridium Difficile and New Infectious Disease Products. Mr. Edwards received a B.S. degree in business and healthcare administration from Ohio University.

Michael Hearne

Chief Financial Officer 

Mr. Hearne has served as our Chief Financial Officer since 2020. Since 2015, he has served as Chief Financial Officer of Tang Capital Management, LLC, a life sciences-focused investment company. Since 2015, Mr. Hearne has also held various positions at Odonate Therapeutics, Inc., most recently serving as Chief Financial Officer since 2018. From 2014 to 2015, he served as a partner at Weaver & Tidwell, LLP. Mr. Hearne started his career in public accounting at Coopers & Lybrand. Mr. Hearne received a B.S. degree in accounting and a masters of accountancy, taxation from Brigham Young University and is a Certified Public Accountant (inactive) in the state of California.

Tony Hodges, M.D., FACP, FCCP

Chief Medical Officer

 

Dr. Hodges has served as our Chief Medical Officer since 2021. From 2016 to 2020, he served in various positions at Banner—University Medical Center Phoenix, including serving as Director of the Center for Lung Transplantation, Director of the Center for Infusion Medicine and Physician Executive Director of Revenue Cycle Operations. From 2006 to 2012, Dr. Hodges was Co-founder and Director of the Center for Thoracic Transplantation and Medical Director of Lung Transplant at the Norton Thoracic Institute at St. Joseph’s Hospital and Medical Center in Phoenix, Arizona. From 2002 to 2006, he served as Medical Director of the Lung Transplantation and Advanced Lung Disease Center at Keck University of Southern California Hospital. Dr. Hodges received a B.S. degree in clinical laboratory sciences and microbiology from Louisiana Tech University and an M.D. degree from Louisiana State University School of Medicine, and completed his Pulmonary and Critical Care and Lung Transplant Fellowships at the University of Colorado Health Sciences Center.

Stew Kroll

Chief Development Officer

 

Mr. Kroll has served as our Chief Development Officer since 2020 and previously as Senior Vice President of Biometrics from 2017 to 2019. Since 2017, he has also held various positions at Odonate Therapeutics, Inc., most recently serving as Chief Development Officer since 2018. From 2005 to 2016, Mr. Kroll held various positions at Threshold Pharmaceuticals, Inc., most recently serving as Chief Operating Officer. From 2000 to 2005, he served as Senior Director of Biostatistics at Corixa Corporation. From 1997 to 2000, Mr. Kroll held various positions at Coulter Pharmaceutical, Inc., most recently serving as Director of Biostatistics. Mr. Kroll received a B.A. degree and an M.A. degree in statistics from the University of California, Berkeley.

Luke Seikkula

Senior Vice President of Pharmaceutical Operations

Mr. Seikkula has served as our Senior Vice President of Pharmaceutical Operations since 2019 and previously held various positions, most recently serving as Vice President of Pharmaceutical Operations, from 2015 to 2019. From 2012 to 2015, he served as Senior Director of Materials and Logistics at Spectrum Pharmaceuticals, Inc. From 2009 to 2012, Mr. Seikkula served as Senior Director of Materials and Logistics at Allos Therapeutics, Inc. Mr. Seikkula received a B.S. degree in business administration from Winona State University and an MBA in finance from San Diego State University.

Steven Ferris

Vice President of Quality Assurance

Mr. Ferris has served as our Vice President of Quality Assurance since 2021. From 2019 to 2021, he served as Vice President of Quality Systems at SQ Innovation, Inc. From 2016 to 2019, Mr. Ferris served as Senior Director of Quality Systems at Tetraphase Pharmaceuticals, Inc. From 2010 to 2016, he served as Director of Quality at Pharmalucence, Inc. (acquired by Sun Pharmaceutical Industries Ltd. in 2014). From 2008 to 2010, Mr. Ferris served as Senior Director of Quality Assurance at ImmunoGen, Inc. Mr. Ferris received a B.S. degree in biology from Rhode Island College.

Paula Rusu

Vice President of Operations 

Ms. Rusu has served as our Vice President of Operations since 2020. From 2018 to 2020, she served as Senior Director of Commercial Operations at Tetraphase Pharmaceuticals, Inc. From 2015 to 2018, Ms. Rusu served as Director of Sales Operations at Collegium Pharmaceutical, Inc. From 2011 to 2015, she served as Director of Field Planning and Effectiveness at Cubist Pharmaceuticals, Inc. (acquired by Merck & Co., Inc.). From 1998 to 2011, Ms. Rusu held various positions at Purdue Pharma L.P., most recently serving as Director of Sales Operations. Ms. Rusu received a B.S. degree in biology and an MBA in general management from Cornell University.

COMPLIANCE

pdf-icon.png
pdf-icon.png